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Abstract
Background: Avian infectious bronchitis is a highly contagious disease of the upper-respiratory tract caused by
infectious bronchitis virus (IBV). Understanding the molecular mechanisms involved in the interaction between
innate and adaptive immune responses to IBV infection is a crucial element for further improvements in strategies
to control IB. To this end, two chicken lines, selected for high (L10H line) and low (L10L line) serum concentration
of mannose-binding lectin (MBL) were studied. In total, 32 birds from each line were used. Sixteen birds from each
line were infected with IBV and sixteen were left uninfected. Eight uninfected and infected birds from each line
were euthanized at 1 and 3 weeks post infection. RNA sequencing was performed on spleen samples from all
64 birds and differential gene expression analysis was performed for four comparisons: L10L line versus L10H line
for uninfected birds at weeks 1 and 3, respectively, and in the same way for infected birds. Functional analysis was
performed using Gene Ontology (GO) Immune System Process terms specific for Gallus gallus.
Results: Comparing uninfected L10H and L10L birds, we identified 1698 and 1424 differentially expressed (DE)
genes at weeks 1 and 3, respectively. For the IBV-infected birds, 1934 and 866 DE genes were identified between
the two lines at weeks 1 and 3, respectively. The two most enriched GO terms emerging from the comparison of
uninfected birds between the two lines were “Lymphocyte activation involved in immune response” and “Somatic
recombination of immunoglobulin genes involved in immune response” at weeks 1 and 3, respectively. When
comparing IBV-infected birds between the two lines, the most enriched GO terms were “Alpha-beta T cell activation”
and “Positive regulation of leukocyte activation” at weeks 1 and 3, respectively.
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Conclusions: Healthy birds from the two lines showed significant differences in expression profiles for subsets of
adaptive and innate immunity-related genes, whereas comparison of the IBV-infected birds from the two lines showed
differences in expression of immunity-related genes involved in T cell activation and proliferation. The observed
transcriptome differences between the two lines indicate that selection for MBL had influenced innate as well as
adaptive immunity.
Keywords: IBV, Coronavirus, Infectious bronchitis, Chicken, RNA sequencing, Transcriptome, Spleen, Mannose-binding
lectin, Immune response
Background
Avian infectious bronchitis (IB) is an acute and highly
contagious disease of the upper-respiratory tract caused
by the infectious bronchitis virus (IBV). The virus is a
member of the Coronaviridae family and has numerous
serotypes and strains. Rapid replication combined with
high mutation rate and recombination are the main
causes of the observed high diversity [1]. The respiratory
tract is the primary target organ and entry point for the
virus, before further spread to kidneys and gonads. The
most common symptoms of IB are related to the re-
spiratory tract and include gasping, coughing, sneezing,
tracheal rales, and nasal discharge [2]. Feed conversion
and average daily gain are affected in broilers, and infec-
tion is often followed by secondary bacterial infections.
In layers, IBV causes a reduction in egg production and
egg quality. Today, IB is one of the most economically
important diseases in the poultry industry [2].
Infection outbreaks are controlled by a combination of
strict management practices and vaccination. The strict
management practices, which include the maintenance
of the housing temperature and ventilation, are essential,
because IBV is highly contagious and spreads very fast.
Live attenuated and inactivated vaccines are widely used
for control and prevention of IBV infection [3, 4]. As
there is little or no cross-protection between different
serotypes/variants of the virus, hence vaccines should
contain serotypes present in a particular area in order to
induce adequate protection [1]. New multi-strain vac-
cines with the optimal antigen combination and optimal
adjuvants are therefore required for future IBV control.
Understanding the molecular mechanisms involved in
the interaction between innate and adaptive immune re-
sponses to IBV infection is a crucial element for further
improvements of the vaccines.
IBV infection induces a wide range of immune re-
sponses in chickens. An innate immune response is acti-
vated during the initial stages of infection in the mucosal
lining of the trachea following binding of IBV virions to
receptors on epithelial cells [5]. Activation of this innate
immune response may be initiated by Toll-like receptor
(TLR) signaling upon IBV recognition [6, 7]. In addition,
rapid activation of natural killer (NK) cells has been
observed one day after IBV infection [8] as well as in-
creased macrophage numbers in lungs and trachea after
primary IBV infection [9]. In the case of the adaptive im-
mune responses, T lymphocyte subpopulations are ac-
tively involved in the early stages of IBV clearance [7, 10]
exhibiting rapid activation upon IBV infection [6]. Fur-
thermore, studies have shown that cytotoxic T lympho-
cytes (CTL) play an important role in responding to
primary infections with IBV [10, 11]. In addition to T cell
responses, IBV specific antibodies, of all three antibody
classes present in chickens, have been reported [12–14]. A
specific local antibody response in avian infectious bron-
chitis is characteristic for the response to a secondary in-
fection [15]. The innate and adaptive immune systems are
strongly interconnected, which is also seen in the re-
sponse to IBV infection, and the connection possibly
involves the serum collectin, mannose-binding lectin
(MBL) as a key player [16].
Two chicken lines which were selected for high and
low MBL serum concentrations (designated L10H and
L10L, respectively), were used in the present study. Se-
lective breeding has been performed for 14 generations
using the combination of two strains (67.5 % UM-B19
chickens and 33.5 % White Cornish) as a starting popu-
lation, as described by Juul-Madsen et al. [17]. The final
result was two divergent lines, with mean MBL serum
concentrations of 33.4 μg/ml for the L10H line and
7.6 μg/ml for the L10L line, respectively [18, 19]. The
mean MBL serum concentration for 14 different chicken
lines representing both broilers and layers is around
6 μg/ml, but varies from 0.4 to 37.8 μg/ml in normal
healthy chickens with protein produced in the liver as
the main source of circulating MBL [17]. In chickens, a
positive correlation between MBL serum concentrations
and the severity of several infections, such as infections
caused by IBV [19], Escherichia coli [20] and Pasteurella
multocida [21], has been observed. Chicken MBL binds
to IBV [16, 22], therefore it is possible that MBL facili-
tates innate responses such as opsono-phagocytosis,
complement activation or virus neutralization, in the
early stages of IBV infection. In mammals MBL has also
been shown to influence induction of adaptive immunity
[23]. In support of the role of MBL in response to IBV,
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Kjaerup et al. [18] observed considerable differences in
cellular adaptive immune parameters in response to an
IBV infection between lines L10L and L10H. Further-
more, birds from L10H line exhibited lower viral loads
and less severe damage of tracheal cilia following the
IBV infection in comparison to birds from the L10L line.
The aim of this study was to characterize the spleen
transcriptome of healthy birds from the two lines se-
lected for serum MBL, and to investigate differences in
molecular mechanisms behind the development of sys-
temic adaptive immunity between the L10L and L10H
lines infected with IBV.
Results
Animal experiment
The experimental timeline and sampling time points are
as illustrated in Fig. 1 and a full description of the ex-
perimental infection is reported by Kjaerup et al. [18].
The birds were infected at 3 weeks of age and from day
2 post-infection (p.i.), showed clinical signs characteristic
of IBV infection, including sneezing and labored breath-
ing. Viral loads in tracheal swabs were assessed for all
birds as reported in the previous paper published on the
experimental infection study [18] . No virus was de-
tected in the uninfected birds at any time point through-
out the experiment. Viral genomes were detected in
swabs from infected birds from day 1 to 8 p.i. Notably,
significantly lower viral loads (p < 0.03) were observed in
birds from line L10H in comparison to infected birds
from line L10L [18].
Detection and quantification of splenic gene expression
RNA sequencing data were produced from eight infected
and eight uninfected birds from each of the two lines at
two sampling occasions, as described in the materials
and methods section. All samples passed quality control
measures for raw and trimmed sequenced reads except
for individual no. 46, which was removed due to a very
low number of sequenced reads. For the remaining
birds, an average of over 37 million reads were obtained
per sample for the 63 samples analyzed, with 81 % of the
reads mapping to the chicken genome reference
sequence, as described in the materials and methods
section (See summary statistics with the number of
mapped and total reads is presented in Additional file 1:
Table S1). In total, 17,113 expressed genes were identi-
fied. After filtering genes with fewer than one read per
million in eight samples [24] (genes which would not
achieve statistical significance for differential expres-
sion), the final list contained 11,292 expressed genes.
Before performing the differential gene expression ana-
lysis, further multivariate analysis was carried out on
the raw and normalized gene count data to identify any
discrepancies.
Multi-dimensional scaling (MDS) plot on expressed
genes between the two lines, L10H and L10L, showed
that they differ considerably in their transcriptome pro-
files for both uninfected and IBV-infected birds [See
Additional file 2: Figure S1]. Moreover, inter-individual
variation in gene expression at week 1 was considerably
higher than that observed at week 3 for both uninfected
and IBV-infected birds [See Additional file 2: Figure S1].
Birds 22 and 47 were separated from the rest on the
MDS plot [See Additional file 2: Figure S1]. However, in-
spection of raw sequence data and mapping parameters
did not identify any technical problems which would ex-
plain the observed out-grouping of these birds. In
addition an interclass principal component analysis
(PCA) was performed using raw and normalized gene
counts. The interclass PCA revealed that the birds 22
and 47 were placed outside the 95 % confidence inter-
vals of their respective treatments [See Additional file 3:
Figure S2]. However, the PCA did not identify any gene
having extreme count profiles which may have contrib-
uted to the transcriptome dispersion of birds 22 and 47
with respect to their treatment groups. Although there
was no clear technical or biological explanation for
their out-grouping, these samples were removed from
further analysis.
Identification of differentially expressed genes
Differential gene expression analysis was performed to
compare the two chicken lines (L10L and L10H) at two
time points for uninfected (C1 and C2, see Fig. 1) and
IBV-infected birds (C3 and C4, see Fig. 1). A large num-
ber of genes were differentially expressed (DE) between
L10L and L10H lines at weeks 1 and 3, for both unin-
fected and IBV-infected birds (see Table 1, see Fig. 1).
We identified 1,698 and 1,424 DE genes for the unin-
fected birds between lines L10L and L10H at weeks 1
and 3, respectively (see Table 1). In total 692 genes had
higher expression in L10H line and 1,006 had higher ex-
pression in line L10L for the uninfected birds at week 1
[See Additional file 4: Table S2] and 774 genes had
higher expression in L10H line and 650 genes had
higher expression in L10L line for uninfected birds at
week 3 [See Additional file 5: Table S3].
Comparing IBV-infected L10H and L10L birds, we
identified 1,934 and 866 DE genes at weeks 1 and 3, re-
spectively (see Table 1). In total 931 genes had higher ex-
pression in line L10H and 1,003 had higher expression
in line L10L at week 1 and at week 3, 508 had higher
expression in line L10H and 358 had higher expression
in line L10L (Table 1, Additional file 6: Table S4 and
Additional file 7: Table S5).
There were also status-related changes in gene expres-
sion as shown in the Venn diagram (Fig. 2). At week 1,
the total number of DE genes in uninfected birds
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Fig. 1 Structure and timeline of the experiment together with comparisons of gene differential expressions. The figure illustrates the experimental
timeline together with the structure of the experiment. In total, 64 birds, 32 from each experimental line, L10H and L10L, were used. In addition,
differential expression comparisons are shown
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between the two lines was 1698 (1077 + 621) (Table 1,
Fig. 2) which is lower comparing to 1934 (621 + 1313)
DE genes in infected birds between the two lines
(Table 1, Fig. 2). Out of 3,011 (1077 + 621 + 1313) DE
genes for both uninfected and infected birds between
the two lines only 621 (~20 %) were common for two
comparisons (Fig. 2). At week 3, the total number of DE
genes in uninfected birds between the two lines was
1424 (883 + 541) (Table 1, Fig. 2) which was higher com-
paring to 866 (541 + 325) in infected birds between the
two lines (Table 1, Fig. 2). When comparing the unin-
fected and infected birds between the two lines, 541
(~30 %) genes were common out of total of 1749 (883 +
541+ 325) DE genes for both comparisons (Fig. 2).
Moreover, we also performed differential gene expres-
sion analysis to compare two time points (week 1 and
week 3) in the two chicken lines (L10L and L10H) for
uninfected (C5 and C6, see Fig. 1) and IBV-infected
birds (C7 and C8, see Fig. 1). Finally, differential gene
expression analysis was also conducted to compare the
two infection states (uninfected and IBV-infected) at two
time points for the L10L chicken line (C9 and C10, see
Fig. 1) and the L10H chicken line (C11 and C12, see
Fig. 1). As our main aim was to investigate differences
between the two chicken lines, we only presented and
discussed results related to the comparisons between the
two chicken lines (C1 – C4, see Fig. 1). Results for the
rest of comparisons (C5 – C12, see Fig. 1) were provided
in the form of supplementary materials [See Additional
file 8: Table S6, Additional file 9: Table S7, Additional file
10: Table S8, Additional file 11: Table S9, Additional file
12: Table S10, Additional file 13: Table S11, Additional file
14: Table S12 and Additional file 15: Table S13].
Functional analysis of differentially expressed genes
An enrichment gene set analysis was carried out to iden-
tify over-represented Gene Ontology (GO) “Immune
System Process” terms using the lists of DE genes from
comparisons between uninfected and infected birds from
the two lines at 1 and 3 weeks p.i. The most enriched
GO Immune System terms between the two lines when
comparing uninfected birds from the two lines and then
infected from the two lines are shown in Fig. 3.
GO Immune System terms associated with genes that
were differentially expressed between the two lines for
uninfected birds at week 1 were “Lymphocyte activation
involved in immune response” (GO:0002285), “Activation
of innate immune response” (GO:0002218), “Lymphocyte
mediated immunity” (GO:0002449), and “Leukocyte
Table 1 Summary statistics of differentially expressed (DE) genes at FDR < 0.05
L10H versus L10L Higher expression in L10H No difference Higher expression in L10L DE-expressed
Uninfecteds at week 1 (C1) 692 9594 1006 1698
Uninfecteds at week 3 (C2) 774 9868 650 1424
Infected at week 1 (C3) 931 9358 1003 1934
Infected at week 3 (C4) 508 10426 358 866
Comparison between the two lines, L10H and L10L, uninfected and infected birds at two time points (weeks 1 and 3). Comparisons C1 – C4 correspond to
differential gene expression comparisons presented in Fig. 1
a
b
Fig. 2 Venn diagram of differentially expressed (DE) genes between
comparisons of uninfected and infected birds at different time
points. a Differentially expressed (DE) genes between lines when the
lines are uninfected (left circle) and infected (right circle). Numbers
in the intersection correspond to DE genes that are in common
between lines for uninfected and IBV infected birds at week 1. b DE
genes between lines when the lines are uninfected (left circle) and
infected (right circle). Numbers in the intersection correspond to DE
genes that are in common between lines for uninfected and IBV
infected birds at week 3. Numbers outside of circles represent sum
of DE genes presented in circles
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differentiation” (GO:0002521) [See Fig. 3, Additional file
16: Figure S3]. In total, 53 DE genes were mapped to the
GO Immune System terms (Fig. 4). Among the DE
genes, TGFB3 (Transforming growth factor beta 3), IL7
(Interleukin 7), FKBP1B (FK506 binding protein 1B),
FAS (Fas cell surface death receptor) and PTPN22 (Pro-
tein tyrosine phosphatase, non-receptor type 22) had a
higher expression in line L10H compared with L10L
[See Fig. 4, Additional file 16: Figure S3]. Furthermore,
the line L10H had a lower expression for a subset of
innate immune genes: TYRO3 (Tyrosine-protein kinase
receptor 3), TRAF3 (TNF receptor-associated factor 3)
and TLR7 (Toll-like receptor 7) compared with L10L
[See Additional file 16: Figure S3, Fig. 4].
For uninfected birds at week 3, the most enriched GO
Immune System terms were “Somatic recombination of
immunoglobulin genes involved in immune response”
(GO:0002204) and the “Adaptive immune response
based on somatic recombination of immune receptors
built from immunoglobulin superfamily” (GO:0002460)
[See Fig. 3, See Additional file 17: Figure S4]. In total, 47
DE genes mapped to GO Immune System terms in this
comparison (Fig. 4). Among the DE genes that had a
higher expression in the line L10H at week 3, in the
uninfected group, were IL7, FKBP1B, FAS and PTPN22,
which were also seen differentially expressed between
lines at week 1 [See Fig. 4, Additional file 17: Figure S4].
Comparing infected birds from the two lines, at week
1, “Alpha-beta T cell activation” (GO:0046631), “Activa-
tion of innate immune response” (GO:0002218) and
“Leukocyte differentiation” (GO:0002521) functions were
the three most enriched GO Immune System terms
(Fig. 3). CXCR4 (Chemokine receptor 4), PTPN22 and
FAS were among the most highly expressed genes in
L10H [See Fig. 4, Additional file 18: Figure S5].
The major GO Immune System term that was strongly
enriched for in the infected birds at week 3 was “Positive
regulation of leukocyte activation” (GO:0002696) [See
Fig. 3, Additional file 19: Figure S6]. Among the DE
genes with higher expression in the L10H line were
CXCR4, VCAM1 (Vascular cell adhesion protein 1),
PTPN22 and JMJD6 (Jumonji domain containing 6) [See
Fig. 4, Additional file 19: Figure S6].
Discussion
The present study used two lines, L10L and L10H,
which have been divergently selected for high and
low MBL serum concentration for 14 generations,
Fig. 3 Functional map of differentially expressed genes enriched for GO Immune System terms. The top categories of the GO Immune System
terms associated with differentially expressed (DE) genes. All categories were statistically significant (adjusted p-value < 0.001). The chart fragments
represent the number of genes associated with the terms as a proportion of the total number of genes within the respective GO term. Terms
which have not been grouped are shown in grey
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respectively. These two lines have earlier been exten-
sively used for immunological studies and exhibit differ-
ences in immunological parameters after being challenged
with several pathogens [18, 22, 25].
The spleen is a secondary lymphoid organ where in-
nate and adaptive immune responses can be efficiently
mounted. In addition, the avian spleen is considered to
play a very important immunological role because avian
lymphatic vessels and lymph nodes are poorly developed
[26]. The transcriptome differences in the spleen be-
tween the two lines, L10L and L10H, for uninfected
(healthy) and IBV-infected birds were investigated, fo-
cusing on the differential expression of immune-related
genes within significantly enriched immune-related GO
terms. Large differences in transcriptome profiles were
observed between birds from the two lines, both unin-
fected (healthy) and following the experimental IBV
challenge [See Additional file 2: Figure S1]. This suggests
Fig. 4 Differentially expressed genes associated with the GO Immune System term. Heatmap representation of the differentially expressed (DE)
genes associated with the GO Immune System terms for the four comparisons between the two lines, L10H and L10L, uninfected and infected
groups at two time points, weeks 1 and 3. The heat map is constructed using the average values of counts per millions for each group
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that selection for MBL serum levels in the two lines had
a much wider effect which goes beyond the expression
of the MBL gene [27]. The observed transcriptome dif-
ferences can probably be attributed to correlated re-
sponse to selection [28] or random genetic drift [29].
Correlated selection occurs when a trait is affected by
selection on a another trait and is dependent on a gen-
etic correlation between the two traits, which is well
known in animal breeding [30]. Alternatively, random
genetic drift could contribute to the observed differ-
ences, considering that the founder population of the
two lines was small [17].
Focusing on the expression of immune-related genes:
at week 1, the uninfected birds showed differences in the
expression of genes involved in both adaptive immunity
and innate immunity-related pathways [See Additional
file 16: Figure S3]. In addition, the line L10H had a lower
expression for the subset of the innate immune genes,
TYRO3, TRAF3 and TLR7 at week 1 [See Additional file
16: Figure S3 and Fig. 4]. TYRO3 encodes tyrosine-
protein kinase receptor 3 (TYRO3) which is involved in
inhibition of TLR signaling pathways and TLR-induced
cytokine signaling pathways. These two pathways influ-
ence immune-related processes, including cell prolifera-
tion/survival, cell adhesion and migration and inhibits
the innate inflammatory response to pathogens [31].
TRAF3 encodes a cytoplasmic signaling protein, which
plays a critical role in the regulation of antiviral response
and viral evasion [32–34]. TLR7 was also among the DE
innate immunity-related genes with higher expression in
the line L10H. Chicken TLR7 has been shown to play a
part in the response to IBV infections [9, 35].
In addition to the differences in the expression profiles
for a subset of innate immune genes, the two lines also
differed in their expression of adaptive immune genes.
Uninfected birds from L10H had a higher gene expres-
sion compared to the line L10L, for TGFB3, IL7,
FKBP1B, FAS and PTPN22. These genes are known to
be involved in a wide range of adaptive immune pro-
cesses. In humans, reducing the TGF-β signaling on T
cells has been shown to increase the function of CD8 T
cells in an indirect way which results in the rapid elimin-
ation of viruses, enabling the creation of an effective
memory response [36]. Similarly, human IL-7 plays a
key role in the survival of both naïve [37] and memory
[38, 39] CD4 and CD8 T cells. Moreover, an in vitro
study showed that inhibition of FKBP1B and other
cyclophilins blocked the replication of different Corona-
viruses, including IBV [40]. In analogy, uninfected birds
from the L10H line had a higher expression of IL7,
FKBP1B, FAS and PTPN22.
Generally the uninfected (healthy) birds from the two
lines exhibit different expression profiles for this subset
of innate and adaptive immune genes probably resulting
from the divergent selection for the MBL serum concen-
tration. Selection in animal breeding have been shown
to have an extensive effect on a variety of traits including
immunological [30]. Moreover, correlated response to
selection has been observed in the case where selection
was performed on less complex traits such as testoster-
one levels [41]. Finally, different expression profiles for
the subset of innate and adaptive immune in the unin-
fected birds from the two lines might be due to the bal-
ance in the effect of MBL serum levels. High levels of
human MBL have been mostly reported as beneficial
while in case of intracellular parasitic disease the effect
of MBL serum level might be opposite [42]. The results
indicate that selection for MBL serum levels might lead
to favoring specific modes of immune responses depend-
ing on the MBL function.
Large differences in the expression patterns were seen
between the two lines following infection with IBV and
these differences involved adaptive immunity-related
pathways which are associated with “Alpha-beta T cell
activation” (GO:0046631), and “Activation of innate im-
mune response” (GO:0002218) [See Additional file 18:
Figure S5]. The observed enrichment for GO terms re-
lated to T cell activation is in accordance with a previous
study of these lines that showed that the IBV-specific T
cells are present in large numbers in the spleen after
IBV infection [43]. At week 1 post infection CXCR4, FAS
and PTPN22 showed higher expression in line L10H.
The CXC chemokine receptors are expressed on both ef-
fector and memory T cells and play a key role in the
homeostasis of memory T cells [44]. FAS has been shown
to be upregulated in the kidney of chickens challenged
with IBV [45]. The Fas/FasL pathway is an important
pathway of killing for cytotoxic T cells [46]. Similarly,
PTPN22 has been shown to be differentially expressed in
chickens following pathogen challenge, and in particular
following infection with Escherichia coli [47].
Additionally VCAM1 and JMJD6 were among the
adaptive immunity-related genes DE between lines at
week 3 [See Fig. 4, Additional file 19: Figure S6]. The
VCAM1 gene is known to be involved in the activation
of T cells [48]. Furthermore, a recent study demon-
strated that JMJD6 regulates proliferation of memory T
cells during a viral infection [49] which is of great inter-
est considering that had higher expression in the IBV-
infected birds from L10H line at week 3.
The results show that the two lines differ greatly in
the expression of adaptive immunity-related genes fol-
lowing infection, which may imply the presence of dif-
ferent modes of gene regulation. The sampling times
were chosen to access responses both in the effector
phase (week 1) and memory phase (week 3) of the adap-
tive immune response to IBV. In accordance, at 1 week,
post infection subsets of genes actively involved in T cell
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proliferation show differences between the lines. Also, at
week 3 immune-related gene expression profiles in re-
sponse to IBV infection that differ between the lines are
more related to maintenance of T cell memory. MBL is
known to be involved in regulation of dendritic cell mat-
uration as well as cytokine production [50]. Dendritic
cells, which are the main antigen presenting cells and
are actively involved in regulation of adaptive immune
responses, possess the receptors for MBL in mammals
[23]. Therefore, the two lines selected for different MBL
serum concentration may display differences in adaptive
immune responses and development of adaptive immun-
ity as a result of differences in response to cytokine sig-
naling from dendritic cells. Other studies of the two
lines, L10L and L10H, have shown that they differ in dis-
ease response parameters after being challenged with
different pathogens. The L10L line has been associated
with increased viral replication in the airway after an in-
fectious bronchitis virus (IBV) infection [18], reduced
growth rate after an Escherichia coli infection [20] and
greater intestinal colonization after Salmonella Infantis
infection [51]. In the present experiment, significantly
lower viral loads (p < 0.03) were observed in birds from
line L10H in comparison to infected birds from line
L10L [18]. Furthermore, L10H birds in the present study
exhibited a less severe damage of tracheal cilia following
the IBV infection in comparison to the L10L line (un-
published data). In the current experiment phenotypic
differences in additional traits connected to adaptive im-
munity were observed, including numbers of circulating
B cells and cytotoxic T cells [18]. Based on these obser-
vations it seems that selection for high MBL serum
concentration allows birds to cope better after being in-
fected with a range of pathogens. Therefore, the ob-
served differences in the expression profiles for the
adaptive and innate immune-related genes are a reflec-
tion of differences in disease resistance and immune re-
sponses between the lines L10L and L10H.
Conclusions
In conclusion, large differences in the spleen transcrip-
tome between the two chicken lines, L10L and L10H,
were observed in both uninfected (healthy) and IBV-
infected birds. The uninfected birds from the two lines
showed differences in expression profiles for a subset of
both adaptive and innate immunity-related genes, which
may represent differences in preparedness to respond to
an infection. Following infection with IBV, the two lines
showed large differences in expression of genes in-
volved in the adaptive cellular immune response such
as T cell activation and proliferation pathways and
hence their ability to respond to the infection, which is
reflected in the difference in pathogen load seen be-
tween the two lines.
Methods
Experimental design and tissue collection
This study is a follow-up of the experiment performed
by Kjaerup et al. [18] which characterized the cellular
and humoral immune response of the two chicken lines,
L10H and L10L, divergently selected for MBL serum
concentrations following IBV infection. In total, 96 birds
were used in the experimental study originating from
the two Aarhus University inbred lines, L10H and L10L
[19]. All 96 birds were reared together in a biosecure
IBV-free environment until they were 3 weeks of age
and then allocated to two different groups with 24 birds
from each line in each group (uninfected and infected).
The birds were transferred to a biosafety level 2 facility
and placed in isolators. Two isolators contained unin-
fected chickens and two isolators contained infected
chickens. Each isolator having an equal mix of the two
lines as described by Kjærup et al. [18].
The virulent IBV-M41 strain was used for the infec-
tion (a kind gift from Dr. med. vet. Hans C. Philipp
at the Lohmann Animal Health GmbH, Cuxhaven,
Germany). The virus had been passaged twice in spe-
cific pathogen-free embryonated eggs. The IBV inoc-
ula were prepared in phosphate-buffered saline (PBS)
immediately before use and contained 2 × 105.2 EID50
/200 μl of IBV-M41 virus. The first and the second
group (the uninfected groups) were mock-infected
with 200 μl PBS per bird. The third and fourth
groups (the infected groups) received 200 μL of IBV-
M41. The inocula were given half nasally and half or-
ally to mimic the natural infection routes of IBV in
the chicken. Chickens were fed diets that met or
exceeded the National Research Council requirements.
Feed and water were provided ad libitum. The birds
were monitored daily for clinical signs of disease and
disease parameters were measured as reported by
Kjærup et al. [18]. None of the individuals received
antibiotic therapy during the experimental period.
The study was carried out under strict ethical ap-
proval and monitoring (see the statement at the end
of the Materials and Methods section).
For this study 64 spleen samples were harvested and
used for RNA sequencing. The birds were sacrificed 1
and 3 weeks post infection by cervical dislocation and
spleen samples were collected. At both time points,
eight samples from the two lines, L10H and line L10L,
from each group (uninfected and infected) were col-
lected as illustrated in Fig. 1. After collection, spleens
were sectioned (triangular cross-sectional slice from
upper part) and identical samples from each chicken
were immediately placed in RNAlater® Stabilization So-
lution (Ambion Inc., Austin, Texas) that were incubated
at 4 °C overnight and then transferred to – 20 °C the
following day.
Hamzić et al. BMC Genomics  (2016) 17:82 Page 9 of 13
RNA extraction and sequencing
Tissue samples were homogenized on a TissueLyzer LT
(Qiagen, Hilden, Germany). Total RNA was extracted with
the Qiagen RNAeasy Kit (Catalog ID 74104, Qiagen,
Venlo, Netherlands) according to the manufacturer’s in-
structions. The quality of the 64 total RNA samples was
verified using a 2200 TapeStation RNA Screen Tape device
(Agilent, Santa Clara, CA, USA) and the concentration
ascertained using an ND-1000 spectrophotometer (Nano-
Drop, Wilmington, DE).
Libraries were prepared with the Illumina TruseqRNA
sample prep kit (Catalog ID FC-122-1001, Illumina, San
Diego, USA) following the manufacturer’s protocol and
evaluated with the Agilent Tape Station 2200. Libraries
were quantified by Picogreen and then normalized to 10
nM as recommended by Illumina for cluster generation
on the Hiseq2000. Equimolar amounts of each library
were mixed before NaOH denaturation.
The Illumina Truseq PE cluster kit v3 (Catalog ID PE-
401-3001) was used to generate clusters on the grafted
Illumina Flowcell and the hybridized libraries were se-
quenced on six lines of a Flowcell on the Hiseq2000 with
100 cycles of a paired-end sequencing module using the
Truseq SBS kit v3 (Catalog ID FC-401-3001).
Quality control, mapping of RNA sequencing reads and
counting mapped reads
Initial control quality was assessed by the FastQC soft-
ware version 0.11.3 [52]. Raw reads were than trimmed
for low quality bases using the Trimmomatic tool version
0.32 [53] applying minimum Phred quality score >10 aver-
aged across the sliding window of five bases. Furthermore,
all reads with the length below 40 bp were removed.
The trimmed reads were mapped to the Gallus gallus
reference genome (Gallus_gallus-4.0, release 80 [54]) using
a spliced aligner TopHat2 version 2.014 [55]. The Gallus
gallus gene annotation used for mapping was retrieved
from Ensembl database version 80 (www.ensembl.org).
The mapping quality was assessed using a set of Python
scripts within the RSeQC toolkit [56]. The quality control
assessment included inspection of the read coverage over
the full gene body in order to assess if reads coverage was
uniform and if there was any 5’ or 3’ bias as well as how
the mapped reads were distributed over genome features.
Gene count estimation was performed using the
HTSeq-count tool in ‘union’ mode. The HTSeq-count is
a Python script within the HTSeq framework, version
0.7.1, which is an open source toolkit that allows the in-
put of raw counts from aligned reads to be annotated
with gene names based on genomic features [57].
Statistical analysis of the differential gene expression
The read counts obtained were used to estimate gene
expression and identify differentially expressed (DE)
genes. This was achieved using Bioconductor package
edgeR version 3.10.0 [58] and limma version 3.24.5 [59]
following a previously described protocol [24]. Before
performing statistical analysis, genes with low levels of
expression were filtered out using a threshold of least
one read per million in n of the samples, where n is the
size of the smallest group of replicates, which in this
case was eight.
In order to account for technical and biological ef-
fects reads counts were normalized using the “calc-
NormFactors” function implemented in the edgeR
package. This function normalizes the data by finding
a set of scaling factors for the library sizes that mini-
mizes the log-fold changes between the samples. The
scale factors were computed using the trimmed mean
of M-values (TMM) between samples [58]. Common
and tag-wise dispersion estimates were calculated with
the Cox-Reid profile adjusted likelihood method in
order to correct for the technical and biological vari-
ation when fitting the multivariate negative binomial
model [60].
Multidimensional scaling (MDS) was implemented in
the edgeR package, to assess similarity of the samples
visually. The MDS plot was created in order to visualize
the relationship between samples and identify possible
outliers [58]. MDS is based on comparing the relation-
ship between all pairs of samples by applying a count-
specific pairwise distance measure [58]. Possible outliers
were further investigated using principal component
analysis (PCA) to remove samples which fell outside a
95 % confidence ellipse.
A design matrix was created in order to specify the
factors that were expected to affect the expression level.
The matrix was constructed to fit the saturated model
where each treatment combination was considered sep-
arately. Eight treatment combinations were considered
as illustrated in Fig. 1: uninfected birds from the line
L10H at week 1, uninfected birds from the line L10L at
week 1, infected birds from the line L10H at week 1,
infected birds from the line L10L at week 1, uninfected
birds from the line L10H at week 3, uninfected birds
from the line L10L at week 3, infected birds from the
line L10H at week 3, infected birds from the line L10L
at week 3.
A generalized linear model likelihood ratio test, speci-
fying the difference of interest, was used to test for
differential expression between these treatment combina-
tions. The differential expression analysis was performed
comparing the log-fold differences in gene counts be-
tween two lines (L10H and L10L) at different time points
(weeks 1 and 3) and for different status (uninfected and
infected) separately (Fig. 1). Benjamini Hochberg false
discovery rates (FDR) for a transcriptome-wide experi-
ment were calculated to correct for multiple testing
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[61]. All genes with an FDR-adjusted p-value <0.05
were considered individual genes of interest and were
retained for further analysis.
Functional analysis of differentially expressed
genes
Functional analysis of the DE genes was performed using
the Cytoscape version 3.2.1 [62, 63] with the ClueGo
version 2.1.7 plug-in [64] to enrich the annotation and
enrichment of the differentially expressed (DE) genes for
four comparisons (C1-C4, see Fig. 1). ClueGO deter-
mines the distribution of the target genes across the GO
(Gene Ontology) terms and pathways: this study focused
on. The p-value was calculated using right-sided hyper-
geometric tests and Benjamini-Hochberg adjustment
was used for multiple test correction. An adjusted p-
value of 0.001 indicated a statistically significant devi-
ation from the expected distribution, and that the corre-
sponding GO terms and pathways were enriched for the
target genes. The association strength between the terms
was calculated using a corrected kappa statistic of 0.4.
The network created represented the terms as nodes
which were linked based on a 0.4 kappa score level. The
size of the nodes reflected the enrichment significance
of the terms. The network was automatically laid out
using the Organic layout algorithm supported by Cytos-
cape. The functional groups were created by iterative
merging of initially defined groups based on the prede-
fined kappa score threshold. Only functional groups rep-
resented by their most significant term were visualized
in the network providing an insightful view of their in-
terrelations [64].
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Availability of supporting data
Raw and analyzed RNA-Seq data for this project have
been deposited in GEO under accession code GSE73423
(http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE
73423). Other supporting data are included as Additional
files 1, 2, 3, 4, 5, 6, 7, 8, 9 and 10.
Additional files
Additional file 1: Table S1. Summary of mapping statistics. Mapping
statistics were obtained from TopHat2 and includes the number of
mapped and total reads after FastQC and Trimmomatic quality control
steps. Birds were assigned to eight different groups according to three
levels: status (infected and uninfected), chicken line (L10L and L10H line)
and time point (weeks 1 and 3). (XLSX 16 kb)
Additional file 2: Figure S1. Multidimensional scaling (MDS) plot
created using expression profiles of all normalized genes. Four MDS plots
were created using the normalized gene count data set. The purpose of
MDS plot is to provide a visual representation of the pattern of
proximities (similarities or distances) among the set of studied birds. Plots
are labeled by eight comparison groups and three different factor levels;
status (uninfected and infected), line (L10L and L10H) and time (weeks 1
and 3). The plot was created using the “plotMDS.dge” function
implemented in the edgeR package. In all plots, L10H_CTL_W1 (red, n =
8), L10H_CTL_W3 (blue, n = 7), L10H_INF_W1 (green, n = 8),
L10H_INF_W3 (purple, n = 7), L10L_CTL_W1 (orange, n = 8), L10L_CTL_W3
(yellow, n = 8), L10L_INF_W1 (brown, n = 6), L10L_INF_W3 (pink, n = 8).
(PDF 6 kb)
Additional file 3: Figure S2. Interclass PCA of normalized gene count
data. Interclass principal component analysis (PCA) with the eight
comparison groups as the instrumental variable. The aim of interclass
PCA was to identify any gene having extreme count profiles which may
have contributed to the transcriptome dispersion of birds 22 and 47 with
respect to their treatment groups. The plot was created using principal
component analysis function implemented in the ade4 R package with
birds as variables and differential expression comparison groups as class
levels. (PDF 13 kb)
Additional file 4: Table S2. Differentially expressed genes (FDR < 0.05)
for comparison between L10L and L10H uninfected birds at week 1.
(TXT 120 kb)
Additional file 5: Table S3. Differentially expressed genes (FDR < 0.05)
for comparison between L10L and L10H uninfected birds at week 3.
(TXT 100 kb)
Additional file 6: Table S4. Differentially expressed genes (FDR < 0.05) for
comparison between L10L and L10H infected birds at week 1. (TXT 136 kb)
Additional file 7: Table S5. Differentially expressed genes (FDR < 0.05) for
comparison between L10L and L10H infected birds at week 3. (TXT 61 kb)
Additional file 8: Table S6. Differentially expressed genes (FDR < 0.05)
for comparison between Week 1 and Week 3 uninfected L10L birds.
(TXT 444 kb)
Additional file 9: Table S7. Differentially expressed genes (FDR < 0.05)
for comparison between Week 1 and Week 3 uninfected L10H birds.
(TXT 235 kb)
Additional file 10: Table S8. Differentially expressed genes (FDR < 0.05)
for comparison between Week 1 and Week 3 infected L10L birds. (TXT
161 kb)
Additional file 11: Table S9. Differentially expressed genes (FDR< 0.05)
for comparison between Week 1 and Week 3 infected L10H birds. (TXT 201 kb)
Additional file 12: Table S10. Differentially expressed genes (FDR <
0.05) for comparison between uninfected and infected L10L birds at
week 1. (TXT 213 kb)
Additional file 13: Table S11. Differentially expressed genes (FDR <
0.05) for comparison between uninfected and infected L10L birds at
week 3. (TXT 107 kb)
Additional file 14: Table S12. Differentially expressed genes (FDR <
0.05) for comparison between uninfected and infected L10H birds at
week 1. (TXT 88 kb)
Additional file 15: Table S13. Differentially expressed genes (FDR <
0.05) for comparison between uninfected and infected L10H birds at
week 3. (TXT 88 kb)
Additional file 16: Figure S3. Network representation of enriched GO
Immune System terms of differentially expressed (DE) genes for
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comparison between uninfected birds at week 1. The GO Immune
System terms were identified as nodes and linked based on their kappa
score level (> = 0.4) and p-value < 0.001. Functionally related groups
partially overlapped. The GO terms are labelled in colors according to
hierarchical clustering of GO terms. Terms which have not been grouped
are shown in grey. The colour pie charts of the GO Immune system
nodes show the gene proportion associated with the respective term.
(PDF 60 kb)
Additional file 17: Figure S4. Network representation of enriched GO
Immune System terms of differentially expressed (DE) genes for comparison
between uninfected birds at week 3. The GO Immune System terms were
identified as nodes and linked based on their kappa score level (> = 0.4) and
p-value < 0.001. Functionally related groups partially overlapped. The GO
terms are labelled in colours according to hierarchical clustering of GO
terms. Terms which have not been grouped are shown in grey. The color
pie charts of the GO Immune system nodes show the gene proportion
associated with the respective term. (PDF 55 kb)
Additional file 18: Figure S5. Network representation of enriched GO
Immune System terms of differentially expressed (DE) genes for
comparison between infected birds at week 1. The GO Immune System
terms were identified as nodes and linked based on their kappa score
level (> = 0.4) and p-value < 0.001. Functionally related groups partially
overlapped. The GO terms are labelled in colors according to hierarchical
clustering of GO terms. Terms which have not been grouped are shown
in grey. The color pie charts of the GO Immune system nodes show the
gene proportion associated with the respective term. (PDF 70 kb)
Additional file 19: Figure S6. Network representation of enriched GO
Immune System terms of differentially expressed (DE) genes for
comparison between infected birds at week 3. The GO Immune System
terms were identified as nodes and linked based on their kappa score
level (> = 0.4) and p-value < 0.001. Functionally related groups partially
overlapped. The GO terms are labelled in colors according to hierarchical
clustering of GO terms. Terms which have not been grouped are shown
in grey. The color pie charts of the GO Immune system nodes show the
gene proportion associated with the respective term. (PDF 30 kb)
Abbreviations
IB: infectious bronchitis; IBV: infectious bronchitis virus; MBL: mannose-
binding lectin; L10L: chicken line selected for low MBL serum levels;
L10H: chicken line selected for high MBL serum levels; DE: differentially
expressed; GO: gene ontology; TLR: toll-like receptor; NK: natural killer;
MHC: major histocompatibility complex; PCA: principal component analysis;
FDR: false discovery rate; PRR: pattern recognition receptors; TGF: tumor
growth factor; PBS: phosphate-buffered saline; MDS: multidimensional
scaling; TMM: trimmed mean of M-values.
Competing interest
The authors declare that they have no competing interests.
Authors’ contributions
EH performed the data analysis and wrote the manuscript. RBK participated
in the animal study, including sample collection and carried out the RNA
isolation. NM participated data analysis, interpretation of results and helped
draft the manuscript. TSD designed and participated in the animal study and
helped draft the manuscript. HJM and EW participated in performing the
animal study. BB helped draft the manuscript. GM, FS, and VG prepared
samples for RNA sequencing, carried out the sequencing and helped with
the initial data analysis. JC: helped with data analysis. JLW was involved in the
study design, and in drafting the manuscript. All authors read and approved
the final manuscript.
Acknowledgements
EH benefited from a joint grant from the European Commission and Cobb –
Vantress Inc. within the framework of the Erasmus-Mundus joint doctorate
“EGS-ABG”. RBK, TSD, HJM, and BB were supported by the project “Development
of genetic selection technology for polyvalent resistance to infectious diseases”
(POLY-REID) (grant number 10-093534) granted by the Danish Council for
Strategic Research, the Danish Poultry Council, The Hatchery Hellevad, and
Cobb – Vantress Inc. This work was also supported by a grant from the
European Union Seventh Framework Network of Animal Disease Infectiology
Research Facilities (NADIR; reference number FP7-228394).
Author details
1UMR1313 Animal Genetics and Integrative Biology Unit, AgroParisTech,
Université Paris-Saclay, 16 rue Claude Bernard, 75005 Paris, France. 2UMR1313
Animal Genetics and Integrative Biology Unit, INRA, Université
Paris-SaclayDomaine de Vilvert, 78350 Jouy-en-Josas, France. 3Department of
Molecular Biology and Genetics, Center for Quantitative Genetics and
Genomics, Aarhus University, Blichers Allé 20, P.O. Box 50, 8830 Tjele,
Denmark. 4Department of Animal Science, Aarhus University, Blichers Allé 20,
P.O. Box 50, 8830 Tjele, Denmark. 5Parco Tecnologico Padano, Via Einstein,
26900 Lodi, Italy. 6University of Milan, DIVET, Via Celoria 10, 20133 Milan, Italy.
7School of Animal and Veterinary Sciences, University of Adelaide, SA 5371
Roseworthy, Australia. 8Cobb-Vantress Inc, US-412 Road, Siloam Springs, AR
72761, USA. 9National Veterinary Institute, Ulls väg 2B, 751 89 Uppsala,
Sweden.
Received: 24 August 2015 Accepted: 18 January 2016
References
1. Jackwood MW, Hall D, Handel A. Molecular evolution and emergence of
avian gammacoronaviruses. Infect Genet Evol. 2012;12:1305–11.
2. Jackwood MW, de Wit S. Infectious Bronchitis. In: Swayne DE, Glisson JR,
McDougald LR, Nolan LK, Suarez DL, Nair VL, editors. Diseases of Poultry.
13th ed. Hoboken: Wiley-Blackwell; 2013. p. 139–59.
3. Meeusen ENT, Walker J, Peters A, Pastoret P-P, Jungersen G. Current status
of veterinary vaccines. Clin Microbiol Rev. 2007;20:489–510.
4. Bande F, Arshad SS, Bejo MH, Moeini H, Omar AR. Progress and challenges
toward the development of vaccines against avian infectious bronchitis. J
Immunol Res. 2015;2015:424860.
5. Abd El Rahman S, El-Kenawy AA, Neumann U, Herrler G, Winter C. Comparative
analysis of the sialic acid binding activity and the tropism for the respiratory
epithelium of four different strains of avian infectious bronchitis virus. Avian
Pathol. 2009;38:41–5.
6. Guo X, Rosa AJM, Chen D-G, Wang X. Molecular mechanisms of primary
and secondary mucosal immunity using avian infectious bronchitis virus as
a model system. Vet Immunol Immunopathol. 2008;121:332–43.
7. Vervelde L, Rosa AJM, Oliverira HN, Rosa GJM, Guo X, Travnicek M, et al.
Transcriptome of local innate and adaptive immunity during early phase of
infectious bronchitis viral infection. Viral Immunol. 2006;19:768–74.
8. Vervelde L, Matthijs MGR, van Haarlem DA, de Wit JJ, Jansen CA. Rapid NK-
cell activation in chicken after infection with infectious bronchitis virus M41.
Vet Immunol Immunopathol. 2013;151:337–41.
9. Kameka AM, Haddadi S, Kim DS, Cork SC, Abdul-Careem MF. Induction of
innate immune response following infectious bronchitis corona virus
infection in the respiratory tract of chickens. Virology. 2014;450–451:114–21.
10. Collisson E. Cytotoxic T, lymphocytes are critical in the control of infectious
bronchitis virus in poultry. Dev Comp Immunol. 2000;24:187–200.
11. Seo SH, Collisson EW. Specific cytotoxic T lymphocytes are involved in in
vivo clearance of infectious bronchitis virus. J Virol. 1997;71:5173–7.
12. Martins NR, Mockett AP, Barrett AD, Cook JK. IgM responses in chicken
serum to live and inactivated infectious bronchitis virus vaccines. Avian Dis.
1991;35:470–5.
13. Raj GD, Jones RC. Local antibody production in the oviduct and gut of hens
infected with a variant strain of infectious bronchitis virus. Vet Immunol
Immunopathol. 1996;53:147–61.
14. Cook KA, Otsuki K, Martins NR, Ellis MM, Huggins MB. The secretory
antibody response of inbred lines of chicken to avian infectious bronchitis
virus infection. Avian Pathol. 1992;21:681–92.
15. Gillette KG. Local antibody response in avian infectious bronchitis: virus-
neutralizing antibody in tracheobronchial secretions. Avian Dis. 1981;25:431–43.
16. Juul-Madsen HR, Norup LR, Jørgensen PH, Handberg KJ, Wattrang E,
Dalgaard TS. Crosstalk between innate and adaptive immune responses to
infectious bronchitis virus after vaccination and challenge of chickens
varying in serum mannose-binding lectin concentrations. Vaccine. 2011;29:
9499–507.
17. Laursen SB, Hedemand JE, Nielsen OL, Thiel S, Koch C, Jensenius JC. Serum
levels, ontogeny and heritability of chicken mannan-binding lectin (MBL).
Immunology. 1998;94:587–93.
Hamzić et al. BMC Genomics  (2016) 17:82 Page 12 of 13
18. Kjærup RM, Dalgaard TS, Norup LR, Hamzic E, Sørensen P, Juul-Madsen HR.
Characterization of cellular and humoral immune responses after IBV
infection in chicken lines differing in MBL serum concentration. Viral
Immunol. 2014;27(10):529–42.
19. Juul-Madsen HR, Norup LR, Handberg KJ, Jørgensen PH. Mannan-binding
lectin (MBL) serum concentration in relation to propagation of infectious
bronchitis virus (IBV) in chickens. Viral Immunol. 2007;20:562–70.
20. Norup LR, Dalgaard TS, Friggens NC, Sørensen P, Juul-Madsen HR. Influence
of chicken serum mannose-binding lectin levels on the immune response
towards Escherichia coli. Poult Sci. 2009;88:543–53.
21. Schou TW, Permin A, Christensen JP, Cu HP, Juul-Madsen HR. Mannan-
binding lectin (MBL) in two chicken breeds and the correlation with
experimental Pasteurella multocida infection. Comp Immunol Microbiol
Infect Dis. 2010;33:183–95.
22. Kjærup RM, Dalgaard TS, Norup LR, Bergman I-M, Sørensen P, Juul-Madsen
HR. Adjuvant effects of mannose-binding lectin ligands on the immune
response to infectious bronchitis vaccine in chickens with high or low
serum mannose-binding lectin concentrations. Immunobiology. 2014;219:
263–74.
23. Downing I, Koch C, Kilpatrick DC. Immature dendritic cells possess a sugar-
sensitive receptor for human mannan-binding lectin. Immunology. 2003;
109:360–4.
24. Anders S, McCarthy DJ, Chen Y, Okoniewski M, Smyth GK, Huber W, et al.
Count-based differential expression analysis of RNA sequencing data using
R and Bioconductor. Nat Protoc. 2013;8:1765–86.
25. Kjærup RM, Norup LR, Skjødt K, Dalgaard TS, Juul-Madsen HR. Chicken
mannose-binding lectin (MBL) gene variants with influence on MBL serum
concentrations. Immunogenetics. 2013;65:461–71.
26. Schat KA, Kaspers B, Kaiser P. Avian Immunology. 2nd ed. Cambridge:
Academic; 2013.
27. Smith JM, Haigh J. The hitch-hiking effect of a favourable gene. Genet Res.
2007;89:391–403.
28. Kean RP, Cahaner A, Freeman AE, Lamont SJ. Direct and correlated
responses to multitrait, divergent selection for immunocompetence. Poult
Sci. 1994;73:18–32.
29. Kimura M. Evolutionary rate at the molecular level. Nature. 1968;217:624–6.
30. Rauw W, Kanis E, Noordhuizen-Stassen E, Grommers F. Undesirable side
effects of selection for high production efficiency in farm animals: a review.
Livest Prod Sci. 1998;56:15–33.
31. Rothlin CV, Carrera-Silva EA, Bosurgi L, Ghosh S. TAM receptor signaling in
immune homeostasis. Annu Rev Immunol. 2015;33:355–91.
32. Paz S, Vilasco M, Werden SJ, Arguello M, Joseph-Pillai D, Zhao T, et al. A
functional C-terminal TRAF3-binding site in MAVS participates in positive and
negative regulation of the IFN antiviral response. Cell Res. 2011;21:895–910.
33. Oganesyan G, Saha S-K, Guo B, He Q-J, Shahangian A, Zarnegar B. Critical
role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral
response. Nature. 2006;439:208–11.
34. Shi C-S, Qi H-Y, Boularan C, Huang N-N, Abu-Asab M, Shelhamer JH, et al.
SARS-coronavirus open reading frame-9b suppresses innate immunity by
targeting mitochondria and the MAVS/TRAF3/TRAF6 signalosome. J
Immunol. 2014;193:3080–9.
35. Iqbal M, Philbin VJ, Smith AL. Expression patterns of chicken Toll-like
receptor mRNA in tissues, immune cell subsets and cell lines. Vet Immunol
Immunopathol. 2005;104:117–27.
36. Delisle J-S, Giroux M, Boucher G, Landry J-R, Hardy M-P, Lemieux S, et al.
The TGF-β-Smad3 pathway inhibits CD28-dependent cell growth and
proliferation of CD4 T cells. Genes Immun. 2013;14:115–26.
37. Schluns KS, Kieper WC, Jameson SC, Lefrançois L. Interleukin-7 mediates the
homeostasis of naïve and memory CD8 T cells in vivo. Nat Immunol. 2000;1:
426–32.
38. Seddon B, Tomlinson P, Zamoyska R. Interleukin 7 and T cell receptor signals
regulate homeostasis of CD4 memory cells. Nat Immunol. 2003;4:680–6.
39. Goldrath AW, Sivakumar PV, Glaccum M, Kennedy MK, Bevan MJ, Benoist C,
et al. Cytokine requirements for acute and Basal homeostatic proliferation of
naive and memory CD8+ T cells. J Exp Med. 2002;195:1515–22.
40. Pfefferle S, Schöpf J, Kögl M, Friedel CC, Müller MA, Carbajo-Lozoya J, et al.
The SARS-coronavirus-host interactome: identification of cyclophilins as
target for pan-coronavirus inhibitors. PLoS Pathog. 2011;7, e1002331.
41. Van Oers K, Buchanan KL, Thomas TE, Drent PJ. Correlated response to
selection of testosterone levels and immunocompetence in lines selected
for avian personality. Anim Behav. 2011;81:1055–61.
42. Dommett RM, Klein N, Turner MW. Mannose-binding lectin in innate
immunity: past, present and future. Tissue Antigens. 2006;68:193–209.
43. Liu G, Wang Q, Liu N, Xiao Y, Tong T, Liu S, et al. Infectious bronchitis virus
nucleoprotein specific CTL response is generated prior to serum IgG. Vet
Immunol Immunopathol. 2012;148:353–8.
44. Chaix J, Nish SA, Lin W-HW, Rothman NJ, Ding L, Wherry EJ, et al. Cutting
edge: CXCR4 is critical for CD8+ memory T cell homeostatic self-renewal
but not rechallenge self-renewal. J Immunol. 2014;193:1013–6.
45. Cong F, Liu X, Han Z, Shao Y, Kong X, Liu S. Transcriptome analysis of
chicken kidney tissues following coronavirus avian infectious bronchitis virus
infection. BMC Genomics. 2013;14:743.
46. Waring P, Müllbacher A. Cell death induced by the Fas/Fas ligand pathway
and its role in pathology. Immunol Cell Biol. 1999;77:312–7.
47. Nie Q, Sandford EE, Zhang X, Nolan LK, Lamont SJ. Deep sequencing-based
transcriptome analysis of chicken spleen in response to avian pathogenic
Escherichia coli (APEC) infection. PLoS One. 2012;7, e41645.
48. Damle NK, Aruffo A. Vascular cell adhesion molecule 1 induces T-cell
antigen receptor-dependent activation of CD4 + T lymphocytes. Proc Natl
Acad Sci U S A. 1991;88:6403–7.
49. Chen C-F, Feng X, Liao H-Y, Jin W-J, Zhang J, Wang Y, et al. Regulation of T cell
proliferation by JMJD6 and PDGF-BB during chronic hepatitis B infection. Sci
Rep. 2014;4:6359.
50. Wang M, Zhang Y, Chen Y, Zhang L, Lu X, Chen Z. Mannan-binding lectin
regulates dendritic cell maturation and cytokine production induced by
lipopolysaccharide. BMC Immunol. 2011;12:1.
51. Ulrich-Lynge SL, Dalgaard TS, Norup LR, Kjærup RM, Olsen JE, Sørensen P, et
al. The consequence of low mannose-binding lectin plasma concentration
in relation to susceptibility to Salmonella Infantis in chickens. Vet Immunol
Immunopathol. 2015;163:23–32.
52. Andrews S. FastQC: A Quality Control Tool for High Throughput Sequence
Data. 2010. http://www.bioinformatics.babraham.ac.uk/projects/fastqc/.
53. Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for Illumina
sequence data. Bioinformatics. 2014;30(15):2114–20.
54. Hillier LW, Miller W, Birney E, Warren W, Hardison RC, Ponting CP, et al.
Sequence and comparative analysis of the chicken genome provide unique
perspectives on vertebrate evolution. Nature. 2004;432:695–716.
55. Kim D, Pertea G, Trapnell C, Pimentel H, Kelley R, Salzberg SL. TopHat2:
accurate alignment of transcriptomes in the presence of insertions,
deletions and gene fusions. Genome Biol. 2013;14:R36.
56. Wang L, Wang S, Li W. RSeQC: quality control of RNA-seq experiments.
Bioinformatics. 2012;28:2184–5.
57. Anders S, Pyl PT, Huber W. HTSeq - A Python framework to work with high-
throughput sequencing data. Bioinformatics. 2014;31(2):166–9.
58. Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for
differential expression analysis of digital gene expression data.
Bioinformatics. 2010;26:139–40.
59. Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. Limma powers
differential expression analyses for RNA-sequencing and microarray studies.
Nucleic Acids Res. 2015;43(7):e47.
60. McCarthy DJ, Chen Y, Smyth GK. Differential expression analysis of
multifactor RNA-Seq experiments with respect to biological variation.
Nucleic Acids Res. 2012;40:4288–97.
61. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical
and powerful approach to multiple testing. J R Stat Soc. 1995;57:289–300.
62. Cline MS, Smoot M, Cerami E, Kuchinsky A, Landys N, Workman C, et al.
Integration of biological networks and gene expression data using
Cytoscape. Nat Protoc. 2007;2:2366–82.
63. Smoot ME, Ono K, Ruscheinski J, Wang P-L, Ideker T. Cytoscape 2.8: new
features for data integration and network visualization. Bioinformatics. 2011;
27:431–2.
64. Bindea G, Mlecnik B, Hackl H, Charoentong P, Tosolini M, Kirilovsky A, et al.
ClueGO: a Cytoscape plug-in to decipher functionally grouped gene
ontology and pathway annotation networks. Bioinformatics. 2009;25:1091–3.
Hamzić et al. BMC Genomics  (2016) 17:82 Page 13 of 13
